Aurinia Pharmaceuticals Inc · NASDAQ:AUPH
Tang Kevin bought 814,606 Aurinia Pharmaceuticals Inc shares (Form 4)
Traded May 29 to Jun 2, 2026 · Filed Jun 2, 2026
From May 29 to Jun 2, 2026, Tang Kevin (Director, Chief Executive Officer, 10% owner) bought 814,606 Aurinia Pharmaceuticals Inc shares at an average US$15.29 for US$12.5M, leaving 13,044,106 shares. Filed Jun 2, 2026 (Form 4).
- Bought
- 814,606 shares
- Price
- US$15.29 average (US$15.28 to US$15.35)
- Value
- US$12.5M
- Holding after
- 13,044,106 shares (held indirectly)
- Trading plan
- No
- Role
- Director, Chief Executive Officer, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Shares | Buy | 2,299 | US$15.35 | 12,231,799 | Indirect |
| May 29, 2026 | Common Shares | Buy | 262,682 | US$15.31 | 12,494,481 | Indirect |
| Jun 1, 2026 | Common Shares | Buy | 343,521 | US$15.28 | 12,838,002 | Indirect |
| Jun 1, 2026 | Common Shares | Buy | 99 | US$15.34 | 12,838,101 | Indirect |
| Jun 2, 2026 | Common Shares | Buy | 206,005 | US$15.28 | 13,044,106 | Indirect |
Source
Related
- Aurinia Pharmaceuticals Inc
- Tang Kevin
- Aurinia Pharmaceuticals Inc shareholders
- Form 4 · Robertson Stephen P. · Sep 11, 2026
- Schedule 13D/A · ILJIN SNT Co., Ltd. · Aug 26, 2026
- Form 4 · Robertson Stephen P. · Aug 25, 2026
- Schedule 13D/A · Tang Capital Management LLC · Jun 4, 2026
- Form 4 · Robertson Stephen P. · May 20, 2026